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Abstract
Background: Residents of care homes have high levels of disability and poor mobility, but the promotion of health
and wellbeing within care homes is poorly realised. Residents spend the majority of their time sedentary which
leads to increased dependency and, coupled with poor postural management, can have many adverse outcomes
including pressure sores, pain and reduced social interaction. The intervention being tested in this project (the
Skilful Care Training Package) aims to increase the awareness and skills of care staff in relation to poor posture in
the older, less mobile adult and highlight the benefits of activity, and how to skilfully assist activity, in this group to
enable mobility and reduce falls risk. Feasibility work will be undertaken to inform the design of a definitive cluster
randomised controlled trial.
Methods: This is a cluster randomised controlled feasibility trial, aiming to recruit at least 12–15 residents at each of
10 care homes across Yorkshire. Care homes will be randomly allocated on a 1:1 basis to receive either the Skilful
Care Training Package alongside usual care or to continue to provide usual care alone. Assessments will be
undertaken by blinded researchers with participating residents at baseline (before care home randomisation) and at
three and six months post randomisation. Data relating to changes in physical activity, mobility, posture, mood and
quality of life will be collected. Data at the level of the home will also be collected and will include staff experience
of care and changes in the numbers and types of adverse events residents experience (for example, hospital
admissions, falls). Details of NHS service usage will be collected to inform the economic analysis. An embedded
process evaluation will explore intervention delivery and its acceptability to staff and residents.
Discussion: Participant uptake, engagement and retention are key feasibility outcomes. Exploration of barriers and
facilitators to intervention delivery will inform intervention optimisation. Study results will inform progression to a
definitive trial and add to the body of evidence for good practice in care home research.
Trial registration: ISRCTN Registry, ISRCTN50080330. Registered on 27 March 2017.
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Background
Life expectancy has increased dramatically over the last
century. As the population ages, the numbers at the old-
est ages will increase the fastest. In mid-2016, there were
1.6 million people aged 85 years and over; by mid-2041,
this is projected to double to 3.2 million [1]. One conse-
quence is an increase in the demand for long-term care
which, despite the increased emphasis on community
care [2], will remain a necessary component of health
and social care provision [3]. The need for care home
places is predicted to rise by 150% in the next 50 years
[4]. Increasing age is associated with increasing disabil-
ity. A United Kingdom (UK) survey [5] reported that
89% of residents of care homes required care because of
disability from long-term conditions, 72% had mobility
problems and 62% were confused.
Residents of care homes are among the frailest in our
population with significant health and social care needs
[6]. The health requirements of residents place consider-
able burden on the UK National Health Service (NHS)
and greater demands are placed on the workload of gen-
eral practitioners (GPs) providing care for care home
residents than caring for people in their own homes [7].
Care home residents are significantly more likely to at-
tend emergency departments by ambulance and be ad-
mitted to hospital compared to the older population
generally [8]. Hospital admission exposes residents to
the risk of nosocomial infections and falls, and is disrup-
tive for this frail population as they struggle to return to
their previous health state once discharged.
The promotion of the health of frail older people in
care homes is poorly and inconsistently developed.
Provision of programmes which could promote health
and wellbeing within UK nursing homes is only patchily
realised [9]. A 2001 survey showed that only 10% of care
home residents receive physiotherapy and just 3% occu-
pational therapy [10]. It is reported that care home resi-
dents spend the majority of their time inactive [11–13]
with low levels of interaction with staff. Previous work
by members of this team [14] indicated that residents
spent up to 13 h of their waking day sedentary. Sedentary
behaviour is adversely associated with chronic disease risk
factors and all-cause mortality [11]. Decreasing mobility,
increasing dependency and poor postural management
have many adverse effects. For residents in care homes,
this may lead to increased incidence of pressure sores,
pain, contractures and loss of independence [15], reducing
opportunities to participate in social activities. Social isola-
tion negatively impacts on mood and self-esteem, which
can then further adversely affect physical health [16].
A Cochrane Review of rehabilitation in long-term care
[17] reported that it was possible to improve physical activ-
ity in this population but that interventions were often
time-limited and resource-intensive. A potentially more
sustainable approach is to enhance the culture in care
homes. To address this, a group of senior physiotherapists
developed and piloted a manualised, competency-based
training programme focused on posture and mobility called
the Skilful Care Training Package (SCTP), which showed
initial promise in raising awareness and providing practical
skills training to staff in early pilot work. This paper de-
scribes the protocol for the feasibility trial evaluation of the
SCTP compared with usual care (UC), within care homes.
Methods / design
Design summary
The PATCH trial is a multicentre, two-arm, pragmatic,
cluster randomised controlled feasibility trial. A sum-
mary of the trial design is illustrated in Fig. 1.
Aims and objectives
The aim of this trial is to assess the feasibility of con-
ducting, and to inform the design of, a definitive rando-
mised controlled trial (RCT) to investigate the clinical
and cost-effectiveness of the SCTP compared with UC,
within care homes. Figure 2 illustrates trial processes
from screening to follow-up.
The objectives are to:
1. Ascertain recruitment and retention rates at the
level of the care home, staff and residents.
2. Assess feasibility and acceptability of follow-up (re-
tention of participants and completeness of data).
3. Assess the appropriateness of outcome measures to
inform the choice of primary and secondary
outcomes for the main trial.
4. Explore and clarify procedures to collect
anonymised data at the level of the home.
5. Assess the feasibility and best methods of collecting
resource and outcome data for a future large-scale
cost-effectiveness analysis. This will also involve ex-
ploration of the reliability of routinely collected
NHS and care home data.
6. Monitor relevant adverse events (AEs) and confirm
how best to collect these.
7. Assess the feasibility of delivering the SCTP.
8. Develop methods to assess compliance with and
adherence to the SCTP.
9. Gain understanding of the barriers and enablers to
delivering and implementing the SCTP in care homes
to optimise implementation in the main trial.
10. Obtain understanding of care home staff and
trainers’ views of the SCTP to inform refinement
for the main trial.
11. Obtain insight from residents as to the acceptability
of the SCTP to inform refinement for the main trial.
12. Assess evidence of proof of concept relating to
potential efficacy.
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13. Ascertain the number of care homes and residents
needed for a definitive trial.
14. Estimate the intra-class correlation coefficient (ICC)
for the selected primary outcome from the trial data
and from other literature and data sources.
Recruitment setting
Ten residential and/or nursing care homes with resi-
dents aged 65 years or older in the counties of West and
North Yorkshire in the UK will participate. These loca-
tions were selected to fit logistically with intervention
delivery and research data collection. This geographical
area covers a range of multi-ethnic rural and urban pop-
ulations, so ensuring generalisability of findings. All care
homes within these counties will be identified from the
Care Quality Commission (CQC) care directory
(accessed via www.cqc.org.uk). They will be approached
if they have no more than four improvements on their
latest CQC inspection report and no inadequate ratings.
First contact with homes will involve sending a study
flyer and summary information sheet to care home man-
agers and following this up with a telephone call where
no response is received. In addition to this ‘mail shot’
approach, the trial will be publicised at suitable local for-
ums for care home managers and organisations and also
by word of mouth by the trial team when they have op-
portunistic contact with care homes. An initial eligibility
check will be undertaken over the telephone with man-
agers at interested homes. If this check is positive, it will
be followed by a visit to establish full eligibility and dis-
cuss trial procedures.
These recruitment processes will continue until 10
homes have been identified.
Care home eligibility
Care homes (as defined above) will be eligible to take
part if they meet all the following inclusion criteria:
Fig. 1 SPIRIT figure. *Further detail is provided in Table 1
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1. The manager has been in post for at least six months
and is likely to remain in post for the study period.
2. The manager is willing and able to release staff to
attend SCTP training sessions and to contribute to
data collection.
3. Training in manual handling is provided to all direct
care staff (a prerequisite for the SCTP training).
4. It is anticipated that 12–15 eligible residents could
be recruited to take part in the trial.
Care homes are not eligible to take part if they meet
any of the following exclusion criteria:
1. Is unsuitable for inclusion due to being subject to
CQC improvements in areas relevant to the trial,
enforcement notices / inadequate ratings,
admissions ban, or relevant moderate or major
compliance breaches.
2. Is receiving special support for specific quality
concerns (e.g. serious safeguarding investigations,
voluntary or compulsory admissions bans).
3. Physiotherapy training which involved postural
management and physical activity has been
delivered to staff in the last 12 months.
4. The SCTP has already been delivered to the home.
Fig. 2 Trial flow diagram
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5. Is taking part in another trial or initiative which
would conflict with the SCTP and / or with data
collection required for this trial.
In larger homes, a particular unit (e.g. nursing unit)
and the associated pool of staff may take part, rather
than the whole home.
Resident eligibility
Following care home agreement to participate, all resi-
dents will be screened for eligibility (anonymously to the
trial team). Researchers will discuss resident eligibility
with care home staff who will identify those who meet
the inclusion criteria and record reasons for ineligibility.
All residents within the home (or participating unit)
will be exposed to the intervention, should the home be
allocated the SCTP; thus all may potentially benefit from
enhanced staff knowledge and skills. Residents who are
more likely to benefit from staff skills acquired during
SCTP training, and where there are no confounding fac-
tors present that may affect outcomes, will be identified.
Thus residents who are aged 65 years or older and are
permanent residents within the home will be considered
for participation in the data collection element of the
trial, whereas those who are independently mobile (a
Functional Ambulatory Classification [FAC] [18] score
of 5 or 6), or who are currently having a course of
physiotherapy, occupational therapy or speech and lan-
guage therapy, or who have a life expectancy of less than
three months will not be eligible to take part. It is antici-
pated that, should the intervention be effective, it would
benefit residents regardless of mental capacity. Excluding
those lacking capacity would affect the generalisability of
the trial results and thus all eligible residents (with and
without capacity) will be approached in line with the
provisions of the Mental Capacity Act (MCA) [19].
Resident recruitment and consent
The home manager or senior staff member will undertake
an initial assessment of the capacity of each eligible resi-
dent to consent to take part in the trial. All residents will
be assumed to have capacity to consent unless assessed to
lack capacity in accordance with MCA guidance.
Where residents have capacity, care home staff will
introduce the trial concept to them. If they are willing to
consider involvement and agree to speak to the re-
searcher, the researcher will discuss the trial in more de-
tail and provide information about the study. Residents
will be offered at least 24 h to consider involvement and
consult with relatives, friends or staff if they wish.
Thereafter, if they are still interested in participating, the
researcher will obtain their written consent.
Where residents lack capacity, consultees will be identi-
fied and approached in line with procedures outlined in
the MCA. Care home staff will identify a relative or friend
who knows each resident well to approach to act as a per-
sonal consultee. The care home manager will send a study
letter and information sheets to identified personal con-
sultees, who will be given 10 days to respond before being
sent a reminder letter and a further seven days to reply.
They will be offered the opportunity to discuss the study
with the researcher. Where a personal consultee does not
respond or is unwilling to take on the role, a nominated
consultee within the care home will be identified to pro-
vide their opinion on the resident’s wishes regarding study
participation. Nominated consultees should be independ-
ent of the research, but in a care home setting this is diffi-
cult. As agreed with the Research Ethics Committee
(REC), nominated consultees must not provide data about
residents to maintain a level of independence from re-
search procedures and should not, wherever possible, be
directly involved in the resident’s care.
Capacity will be monitored on an ongoing basis, as
will the availability of personal consultees. Any loss of
capacity or changes in consultee would result in seeking
a new consultee to facilitate continued participation.
Staff involvement
Active involvement of care home staff is crucial to the
trial. All nursing and care staff will be invited to take part
in the study at each time point, with the exception of bank
or agency staff who have worked in the home for less than
one month during the preceding six months.
All eligible staff will be asked to provide data about
themselves and their role, with some also asked to pro-
vide data about participating residents. If the care home
receives the intervention, staff will be asked to attend
training and will be invited to participate in the process
evaluation interviews.
Staff members will be given a study information sheet
before baseline data collection and again before each
follow-up time point to ensure all currently employed care
and nursing staff are aware of trial processes. Staff involved
in specific roles (e.g. providing data about a resident) will
be provided with a short supplementary information sheet
about their role at the time of taking it on.
Care home randomisation
Following confirmation of eligibility and consent (or con-
sultee agreement), and subsequent to baseline assessments
with/about participating residents, at the level of the home
and from individual staff members, care homes will be
randomised on a 1:1 basis to receive SCTP or UC. Ran-
domisation will be performed by the statistical team at the
Clinical Trials Research Unit (CTRU), using block ran-
domisation with randomly selected block sizes. Conceal-
ment of sequencing is ensured by the physically separate
locations of the CTRU and the blinded study researchers.
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Following randomisation, the CTRU statistical team will
inform the unblinded members of the research team of
the randomisation outcome, so that arrangements for
training in the intervention can be made for those homes
allocated SCTP. Unblinded members of the research team
will be informed of the random allocation of the last two
homes at the same time, to avoid predictability of care
home allocation and selection bias in the recruitment of
homes and/or residents. An unblinded member of the re-
search team will inform the care home manager of the
treatment allocation by telephone and email. This same
member of the team will arrange follow-up visits with
managers in an effort to keep researchers undertaking
outcome assessment blind to allocation throughout the
trial. This will ensure researcher follow-up visits are not
arranged at the same time as intervention training ses-
sions within the home and will allow reinforcement of the
need to not divulge allocation details.
To ensure sufficient outcome data for evaluation at six
months, despite initial assessment that there should be
12–15 eligible residents at a participating care home, a
minimum of eight participating residents will be ac-
cepted for homes to proceed to randomisation.
Intervention
The SCTP is a competency-based, manualised training
programme which evolved through review of the evi-
dence, needs analysis and expressed requirements of
care home staff.
The training course aims to increase the skills of care
assistants and nursing staff in handling techniques (to
facilitate movement) and to promote good positioning
(to maintain functional posture) thus protecting body
shape, avoiding choking, reducing pain and encouraging
activity, so enabling residents to be as active and inde-
pendent as they wish to be. The course is designed to be
delivered to all those providing care (care assistants and
nursing staff ) rather than to be cascaded down to staff
via the training of key workers. The course is practical
in nature and emphasis is given to person centred care
and the development of empathy towards residents.
SCTP will be delivered by expert physiotherapists
(trainers) to staff in each of the five care homes rando-
mised to the intervention arm. Two trainers are
co-applicants who have developed the SCTP, and all four
trainers are qualified physiotherapists who each have
recognised training qualifications. Together they have
optimised the training package for use within the trial
and have undertaken detailed training and development
work to ensure quality and consistency of delivery.
Course content is manualised to ensure consistency,
but the emphasis will be adapted according to the par-
ticular needs of a home and individual staff members.
This will be done in consultation with the care home
management team after randomisation and before the
first training session. The SCTP is generally presented in
three 2.5-h sessions with a ratio of one trainer to a max-
imum of eight staff, but can be presented over two or
one longer session(s) if this fits better with staff availabil-
ity and training plans.
Usual care
Control homes will continue to provide care as usual
with no additional interventional input as a result of trial
participation. No restrictions will be placed on homes
undertaking additional training or development as part
of their usual care. Data will be collected by researchers
from care home managers at all 10 homes to describe
usual care, any changes in practice over the duration of
the trial, new procedures or care processes adopted by a
home during the study period and staff turnover levels.
Data collection
As the intervention will be delivered at the whole home
level, it is important to assess the impact on the whole
home. Thus data will be collected at the home level and
from all care and nursing staff, as well as from and about
participating residents. Data will be collected at baseline
(before randomisation) and at three and six months post
randomisation by blinded trial researchers who will visit
each home at each time point. Maintenance of blinding
will be monitored and reported by researchers as soon
as they become aware of a care home’s allocation.
Personal details of participating residents will be held
centrally, in accordance with the terms of consent or
consultee agreement, to facilitate contact at follow-up
time points. They will be held separately (both paper
and electronic copies) to all outcome data.
A summary of assessments and outcome measures can
be found in Table 1.
Care home level data
At each time point, the care home manager or a nomi-
nated staff member will be asked to provide data to inform
the staff and resident profile of the home. This will in-
clude: ownership (independent or part of a chain); number
of beds in the home; full-time equivalent number of staff;
engagement with local services (for example, community
matron); and presence of specialist units (for example, de-
mentia units). They will also be asked to provide details of
their manual handling policy, staff training and any new
initiatives they may be undertaking.
Anonymous home-level data will be collected on mor-
tality, residents’ pressure areas, number and duration of
hospital admissions, number of visits by health profes-
sionals, and falls for the six months before randomisa-
tion and for the duration of a home’s participation. For
safety monitoring purposes whole-home falls,
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Table 1 Summary and timing of assessments
Assessment Method of completion Timeline
Screening Baseline 3 months 6 months
Screening, eligibility and consent
Care home screening and eligibility Researcher assessment /
Researcher Interview (M)
X
Resident screening and eligibility Staff assessment with
researcher support (S)
X
Anonymous resident data: Physical Activity and Mobility in





Trial consent (including process evaluation)
(Resident (incl. personal/nominated consultee))




(Resident (incl. personal/nominated consultee), staff informant
Researcher assessment (R, S, SI, RF) X (X) (X)
Process evaluation consent Self-completion (S) X X
Care home level data
Care home demographics (including staff profile and training) Researcher interview (M) X X X
Home level resident profile Researcher interview (M) X X X
Significant events (D&V, temporary closure, CQC findings,
change of manager/owner) and staff welfare
Researcher interview with
manager / delegate (M)
X X
Adverse events: total no. resident falls, hospitalisations
and deaths
Researcher telephone interview
with manager / delegate (M)
Collected monthly
Staff measures (about the member of staff)
Demographics Self-completion (S) X X X
Posture and movement questionnaire Self-completion (S) X X X
Kiersma-Chen Empathy Scale Self-completion (S) X X X
Person-Centred Care Assessment Tool (P-CAT) Self-completion (S) X X X
Resident measures (about the resident)
Self-reported pain (Iowa Pain Thermometer) Researcher interview /
self-completion (R)
X X X
Perceived health (EQ-5D-5 L) Researcher interview (R) X X X
Six-item cognitive impairment text (6-CIT) Researcher interview (R) X X X
Posture observation tool Researcher observation (R) X X X
Staff-completed measures (about the resident)
Activities of daily living (ADL) Barthel Index Researcher interview (SI) X X X
Perceived health (EQ-5D-5 L Proxy) Researcher interview (SI) X X X
Continuing Care Ability Measure (CCAM) Researcher interview (SI) X X X
PAM-RC Researcher Interview (SI) X X X
FAC Researcher Interview (SI) X X X
Resident information from care home records / staff
Co-morbidities Researcher collection from notes X X X
Healthcare resource use Researcher collection from notes X X X
New therapies (individual) started since baseline Researcher collection from notes X X
Pressure sores, falls, hospital admissions Researcher collection from notes X X X
Usual care and intervention data
Observations of staff and resident interactions Researcher observation X X X
Usual care details (inc. new procedures or care processes) Researcher interview (M) X X X
Intervention fidelity and adherence
(training, content, delivery, attendance)
Physiotherapist assessment (S) X X
Process evaluation data
Views of intervention (inc. enablers and barriers) Researcher interviews (S, R) X X
M care home manager, R resident, S care home staff, SI staff informant, RF relative/friend
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hospitalisations and mortality will also be collected via a
researcher telephone call to the care home manager on a
monthly basis post randomisation.
At baseline, as part of the screening process, and again
at each follow-up time point, anonymous PAM-RC [20]
and FAC [18] data will be collected for all residents to
establish the activity and mobility profile of the home,
and to establish the representativeness of the resident
population taking part in the trial.
Resident level data
Residents will complete the EuroQol 5-Dimension 5-Level
(EQ-5D-5 L) [21, 22], the six-item Cognitive Impairment
Test (6CIT) [23] and provide a self-reported pain assess-
ment [24] via researcher interview, where they are able.
A purposely developed postural assessment tool will
be completed via researcher observation of participating
residents’ posture. This tool has been developed specific-
ally for use in this trial after an extensive search revealed
no appropriate existing tools to measure observed seated
posture that would be suitable for use by non-expert
staff (researchers who would not be able to physically
examine the residents when observing them). Observa-
tion of the position of specific areas of the body (e.g. pel-
vis, thoracic spine) will occur at two time points
separated by at least 1 h to allow assessment of any pos-
tural change or observation of sustained static seated
position. Researchers will be trained in use of the tool by
qualified physiotherapists.
The Activities of Daily Living (ADL) Barthel Index
[25], Continuing Care Ability Measure (CCAM) [26]
and EQ-5D-5 L proxy will be completed via researcher
interview with each participating resident’s identified
staff informant (a member of staff who knows the resi-
dent well).
Researchers will also collect information from care
home notes for each recruited resident. This includes
relevant co-morbidities, healthcare resource use, pres-
sure sores, falls, NHS and social care contacts. In
addition to collecting this data from care home notes,
and in order to optimise data collection methods for the
definitive trial, alternative data sources such as NHS
Acute Trust records and NHS primary care notes sys-
tems will be explored. Participant information provision
and consent includes these alternative methods of data
collection. This will contribute to both the health eco-
nomic analysis and safety profiles.
Staff data
All eligible care and nursing staff will be asked to
complete a staff booklet which includes demographic
data (e.g. role in the home, training undertaken), a pur-
posely designed questionnaire to elicit their knowledge
of posture and movement, the Kiersma-Chen Empathy
Scale [27] and the Person-Centred Care Assessment
Tool (P-CAT) [28]. These questionnaires have been
chosen to reflect anticipated changes in knowledge, skills
and attitude following SCTP training.
Staff will be asked to return completed questionnaire
booklets in a sealed envelope, either directly by post to
the research office or to a secure box located within the
care home. Consent will be assumed by completion and
return of the booklet.
Process evaluation
A mixed method approach will be adopted to explore
the delivery and implementation of the SCTP.
Data regarding attendance, engagement, content and
delivery of the SCTP will be provided by the trainers after
every session in each of the five SCTP homes. This will be
recorded on trial proformas which will allow reporting of
adherence to the training content and schedule, as well as
providing a summary of the level of staff understanding
and engagement from the trainers’ perspective. Trainers
will also have the opportunity to document any successes
or difficulties, as well as deviations from the training plan,
to allow for real-time reflection.
Observations of the delivery of a sample of the training
will be conducted in each intervention home. Verbal
consent for the researcher to observe the training will be
obtained from trainers and care staff at the beginning of
each session. If consent is not given by all members, the
session will not be observed. The researcher will take
brief summary notes during the training session and will
develop these into expanded fieldwork notes as soon as
possible after the session; this approach provides the op-
portunity to record data in more depth and detail than
is possible during an observation [29]. Semi-structured
interviews will be conducted with a maximum variation
purposive sample [30] of participating care staff in the
five intervention homes following the three- and
six-month assessment points. The aim of this sampling
approach is to explore how the intervention is perceived,
understood and engaged with by different care home
staff in the intervention sites at the different time points.
The sample will vary in relation to staff roles (i.e. man-
agers, qualified nurses, senior care staff and care assis-
tants) and experience (i.e. length of time working in care
homes). Interviews are anticipated to take approximately
45–60 min and will be conducted until the point of data
saturation [31]. Interviews will cover topics such as:
views of the training; what worked (success factors);
what was less successful; knowledge; perspectives and at-
titudes towards residents’ posture and staff ’s handling
skills; and reflections on perceived or actual change in
practice. After the final training session has been deliv-
ered, the trainers will also be asked to participate in a
semi-structured interview that will explore their views
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and experiences of the training, elements that worked
well and not so well, and their views on how care staff
received the training. In order to obtain insight into resi-
dents’ views of their daily routines in the care homes
and their experiences of any changes following the intro-
duction of the intervention, informal conversational
qualitative interviews will be undertaken with a purpos-
ive sample of residents who have participated in the trial
and who have given informed consent as part of their
agreement to trial participation. A sample of 8–12 resi-
dents in total, with differing physical and cognitive impair-
ments drawn from the care homes participating in the
process evaluation, will be sought. The interview format
will be flexible in nature (in relation to the length of time
the interview takes and the manner in which the re-
searcher engages with the residents) in order to engage
residents who may have differing communication and
cognitive abilities. Interview topic guides will be devised
drawing on the published literature relating to care home
care practices and skills training and in consultation with
the research team. Topic guides may be refined in light of
ongoing data collection and analysis. Interviews will be
conducted in a quiet private area and, with permission,
audio-recorded. Informed consent specific to interview
participation will be obtained from care staff and trainers.
To allow reporting of intervention enactment (using
new skills in practice) in a future definitive trial, a
trial-specific observational tool designed to record in-
stances of care behaviours reflective of skills (that could
have been) learned during SCTP training will be devel-
oped and tested in more than one site. A process con-
sent approach will be used for these observations, with
researchers explaining their purpose to all individuals
present on each occasion observations take place. Verbal
consent from staff, care home residents and visitors will
be sought on each occasion observations are undertaken.
Observations will only take place in public areas of the
care homes and only if there is no objection from any-
one within that area.
Economic evaluation
The feasibility work will be used to test the performance
of the data collection forms and methods. For the
EQ-5D-5 L (and proxy EQ-5D-5 L) it is anticipated that
performance will include assessment of clarity of concept
(as evidenced by number of missing data (> 75% com-
pleted)). Integral to this part of the study is the acceptabil-
ity of the EQ-5D-5 L (and proxy EQ-5D-5 L) to residents
and their staff informants, evidenced by completion.
The feasibility of obtaining routinely collected health
service use data from hospital records and GP adminis-
trative systems (e.g. SystmOne) in the timeframes re-
quired will be assessed. This will be compared against
collection of data from care home notes (as described
earlier) to assess the optimal methods of data collection
for this population and in this setting.
Training details (number of sessions, number of at-
tendees, number of trainers and duration of sessions)
will be collected in order to provide a detailed break-
down of the cost of delivering the intervention.
Sample size
The trial is designed to determine feasibility, not to
evaluate effectiveness; therefore a formal power calcula-
tion is not appropriate. However, since we wish to assess
whether change in our proposed primary outcome for a
definitive trial, the PAM-RC, is feasible it is important
that we have sufficient participants to make a prelimin-
ary and non-definitive randomised comparison of SCTP
with UC. Our target sample size of 10 homes, each with
12–15 residents, allows us to detect a minimally import-
ant clinical difference of 0.5 standard deviation (SD)
units with 80% power, a more relaxed false-positive error
rate of 0.20 appropriate at this stage of the evaluation,
25% loss to follow-up and an ICC of 0.03 to 0.05.
Analysis
Quantitative analysis
The analysis plan outlined here will be reviewed and a
final, more detailed statistical analysis plan will be writ-
ten before any analysis is undertaken. Any changes to
the finalised analysis plan and reasons for change will be
documented. Final analysis will be carried out when all
available outcome data have been received. Analyses will
focus on descriptive statistics and confidence interval
(CI) estimation, with the exception of potential efficacy.
The recruitment strategy will be assessed by summar-
ising the screening, eligibility, consent and randomisa-
tion stages at both the care home and resident level.
Care home and staff demographics will be summarised
to inform the context in which the trial was conducted.
Delivery of the SCTP will be evaluated by summarising
staff attendance at the sessions, as well as feedback on
engagement, content and delivery of the sessions. This
will be assessed alongside the qualitative analysis from
the process evaluation.
To assess feasibility and acceptability of follow-up, reten-
tion of homes and residents—including the number, tim-
ing and reasons for withdrawal—will be reported by trial
arm to examine whether there are any systematic differ-
ences between the arms which could be attributed to the
intervention. The difference in follow-up rates between
the arms and corresponding CI will also be reported.
To inform the choice of primary and secondary out-
comes for a definitive trial, completeness of outcome
data will be summarised overall and by arm to assess
both the acceptability of the measures and methods for
collecting the data in a definitive trial. Point estimates
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and variability (SD) of the outcomes at each time point
will be calculated by arm, together with 80% CIs for the
difference in outcomes between the arms at six months
using methods appropriate for cluster randomised trials
with a small number of clusters [32]. The amount of
missing data will also be presented.
To obtain a preliminary and non-definitive rando-
mised comparison of the SCTP with UC for the
PAM-RC, hypothesis testing will be conducted at the
20% significance level using the t-test on care home
(cluster) level summaries. Adjustment for covariates will
be carried out using a two-stage process. At the first
stage, a standard regression model including the covari-
ates of interest, but excluding the intervention effect,
will be fitted to calculate cluster-specific expected values.
Expected and observed values will be compared by com-
puting a residual for each cluster. These cluster level re-
siduals will then be analysed using methods based on
the t-test in the second stage of analysis [31].
To inform the sample size/power calculation for a de-
finitive trial, the SD of the PAM-RC score in the inter-
vention and control arms will be assessed to confirm the
SD to be used. The minimum clinically important differ-
ence will be established via the mean scores (and 80%
CIs) in the control arm and by seeking clinical opinion.
An estimate of the clustering effect (ICC) and 95% CI as
well as cluster-size variation (coefficient of variation) re-
lating to the PAM-RC will also be provided.
AEs, pressure sores, number of resident falls, hospitali-
sations and deaths will be summarised by arm to assess
the safety of conducting a trial in this setting. Staff phys-
ical health issues and sickness levels will also be sum-
marised by arm to ensure that the intervention is not
having a negative impact on staff wellbeing.
Qualitative analysis
Transcribed interviews and fieldwork notes will be en-
tered into NVivo computer software to facilitate man-
agement of a large dataset and the analytic process. A
thematic framework approach [33] to data analysis will
be employed to develop understanding of the facilitators
and barriers to implementation of the SCTP in the care
homes. Particular attention will be paid to staff ’s views
and experiences of the programme as well as the factors
that facilitate or inhibit delivery or sustainability of the
intervention over time. Findings will inform the develop-
ment of the implementation process for a full-scale trial.
Economic analysis
While the primary aim of the economic analysis is to test
the feasibility of data collection for any subsequent RCT,
analysis of the data collected will include descriptive statis-
tics of the resources used. Unit costs for health service re-
sources will be obtained from national sources such as the
PSSRU [34], the BNF [35] and NHS Reference cost data-
base [36]. The perspective of the NHS will be adopted.
Progression criteria for continuation to a definitive
randomised controlled trial
Guidelines for progression to a definitive RCT are based
on a traffic light system of green (proceed to RCT de-
sign), amber (review RCT design and/or implementa-
tion, then proceed) and red (stop and do not proceed).
Progression would be contingent upon meeting success
criteria in the areas of participant recruitment, interven-
tion delivery, data collection and follow-up. Progression
criteria are detailed in Additional file 1.
Trial organisation and governance
The PATCH trial is sponsored by the Bradford Teaching
Hospitals NHS Foundation Trust and is coordinated by
the Academic Unit of Elderly Care and Rehabilitation
(Bradford Teaching Hospitals NHS Foundation Trust and
University of Leeds) and the Clinical Trials Research Unit
(CTRU) at the University of Leeds. The trial management
group consists of the co-applicants and the teams from
the coordinating units. The study will be conducted in ac-
cordance with the Research Governance Framework for
Health and Social Care (2005) and CTRU standard operat-
ing procedures. The study protocol was written in line
with the Standard Protocol Items: Recommendations for
Interventional Trials (SPIRIT) 2013 Statement [37] and is
reported in line with CONSORT 2010 statement’s exten-
sion to randomised pilot and feasibility trials [38, 39].
The SPIRIT checklist can be found in Additional file 2.
Overall trial supervision will be provided by the Trial
Steering Committee (TSC) which will have an independ-
ent Chair. A sub-group of the TSC will perform a safety
monitoring function since a separate Data Monitoring
and Ethics Committee is not required for a feasibility
trial of this nature and duration.
A patient and public involvement (PPI) group will be
separately convened through existing networks at the Aca-
demic Unit of Elderly Care and Rehabilitation. They will be
consulted at key time points during the trial to provide in-
put to the content of participant materials, the acceptability
of measures, any problems encountered with recruitment,
interpretation of findings and dissemination of results.
Data will be entered, managed and monitored for quality
and completeness by the CTRU. Missing data (except in-
dividual items collected via questionnaires) will be chased
until received, confirmed as not available or the trial is at
analysis. Data will be stored and managed in accordance
with the provisions of the Data Protection Act (1998).
Dissemination
Results of the study will be published in peer-review
publications and will be presented at national and
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international conferences. We will work with the PPI
group to develop lay reports to disseminate research
findings to resident and relative groups and the care
home staff at participating homes.
Authorship will be agreed in accordance with the PATCH
trial publication policy and in line with International Com-
mittee of Medical Journal Editors recommendations.
Discussion
The project team have built on their research experience in
care homes [40, 41] to optimise implementation of this
feasibility trial. This includes care home identification using
the CQC database and personal engagement with a net-
work of homes who have previously participated in re-
search. Data collection methods focus on provision of data
from multiple sources (residents, staff and routine data) to
facilitate involvement of a generalisable sample of residents,
i.e. those with and without capacity to consent who may or
may not be able to provide information about themselves.
While this feasibility trial aims to refine recruitment
of, and data collection from, care home residents and
staff, a key focus relates to intervention delivery, receipt
and enactment. This is a novel intervention which has
not had widespread use; thus monitoring of implementa-
tion and exploration of barriers and facilitators that may
hinder delivery and impact resident and staff experiences
is critical. This will allow the team to further develop
implementation procedures to optimise uptake in a de-
finitive trial. Outcomes from the feasibility trial will in-
form processes for delivery of the definitive trial, as well
as adding to the body of evidence for good practice in
care home research.
Trial status
The study is currently working to protocol version 5.0,
dated 10 November 2017. Recruitment of care homes
commenced in February 2017 and recruitment of resi-
dents in May 2017. As of 23 February 2018, nine care
homes have been randomised with 124 residents re-
cruited at these homes. The study has completed site se-
lection and is projected to complete recruitment and
randomisation by the end of February 2018.
Additional files
Additional file 1: PATCH Study Progression Criteria. This document
includes the red, amber and green criteria for progression to a definitive
RCT. (DOCX 22 kb)
Additional file 2: PATCH SPIRIT Checklist. This is the completed SPIRIT
checklist, indicating where all required elements of an interventional trial
protocol are included in this manuscript. (DOC 123 kb)
Additional file 3: Information and consent materials. This document
includes the most recent, REC-approved participant information and
consent materials for residents, personal consultees, nominated
consultees and care home staff. (PDF 1591 kb)
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